Tambo E, Almeer H and Alshamrani Y
Background: Cosmeceutical regulatory and legislation framework continue to play a significant role in beauty and care companies and biotechnology establishment and market expansion worldwide. Comparably, in local high quality cosmeceutical and international brands production and marketing innovations is one of the fastest growing sectors with economic benefits in the Kingdom. This article examines cosmeceuticals market landscape and investment opportunities insights important market investment, opportunities-driven demand and emerging economy in saudization and employment growth in Saudi Arabia.
Results: Our findings showed that there is a growing need to enhance and build partnerships and collaborations in improving pharmaceuticals including cosmeceuticals investments, networks and platforms to move forward market diversification and growth in the Kingdom. Moreover, adequate and efficient harmonization and regulatory processes are vital in accelerating the current empowerment, sustainable economic and social gains and benefits including increasing saudization. Fostering comprehensive health and beauty products regulatory compliance and capacity development in existing and new products premarket approval, ingredient control and labeling warnings and marketing best practices. Notably, constant cosmetovigilance nationwide is vital for evidence-based solutions in flourishing new cosmeceutical firms and market needs and demand. Promoting import and export minimize clearance approval barriers and challenges, scaling up market openness to international competition, while ensuring consumers safety is crucial.
Conclusions: Cosmeceutical industry and market has great potential to change population perception, acceptance, uptake and utilization of beauty and personal care products. With increasing fascination among young vibrant populations including annual large Muslim pilgrims and visitors, the cosmeceuticals product market partnerships and investment technology advancements should be supported in new emergence potential strategic market ties and solutions.
PDFShare this article
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report